FDA Inspection 1077730 — AndersonBrecon Inc.
The FDA completed an inspection of AndersonBrecon Inc. on December 5, 2018 in Rockford, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 5, 2018
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Rockford, IL (United States)